Cactus Life Sciences’ Top 5 Trends of 2024: Insights Driving Tomorrow’s MedComms
Here, we revisit our most thought-provoking articles and whitepapers, each addressing pivotal trends that influence the ever-evolving biopharma landscape...
Read MoreTop Stories
The Paradigm Shift from Traditional Scientific
In the rapidly evolving biopharma landscape, the approach to...
It’s Never Too Soon: How and When to
Engagement with Medical Affairs is critical at every...
Leveraging Social Media to Transform Medical
This whitepaper explores the role of social media in...
Filter
What do Healthcare Professionals Want from Medical Affairs Post COVID-19?
Here's an interesting read for medical affairs teams on how to cater to the digital...
A 4-Step Plan to Drive HCP Engagement
HCPs are a time-constrained and hard-to-engage audience. Learn how pharma can digitally engage HCPs better...
Promoting Diversity and Inclusion in Clinical Trials – New England Journal of Medicine’s New Policy
Read this update on how the New England Journal of Medicine is trying to promote...
Pharma, Physician, and Patient Pain Points Regarding Clinical Trials
Pharma, physicians, and patients consistently face challenges related to clinical trials. Here's a quick look...
Clinical Trial Summaries – What Are They and Why Do They Matter for Pharma?
A majority of patients feel lay summaries for clinical trials are very important and won’t...
How to Incorporate and Drive Equity, Diversity, and Inclusion in Medical Communications and Publications
A roadmap on how to drive advocacy for EDI in medical communications and publications and...